Local
Apotex launches Axitinib Tablets in the U.S., the first generic version of INLYTA®
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Newnan Times-Herald

TORONTO, Nov. 16, 2026 /PRNewswire/ -- Apotex Health Corp. ("Apotex") (TSX: APTX) today announced the U.S. launch of Axitinib Tablets, 1 mg and 5 mg, the first generic version on INLYTA ®, a kinase inhibitor indicated for the treatment of…
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Newnan Times-Herald


